共 50 条
- [4] Newly diagnosed multiple myeloma: Do we need to propose thromboprophylaxis? REVUE DE MEDECINE INTERNE, 2012, 33 (12): : 693 - 696
- [5] What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial Journal of Thrombosis and Thrombolysis, 2019, 48 : 315 - 322
- [6] What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) : 315 - 322